Related Experiment Videos
Whither therapeutics? An enquiry into drug use from historical principles: Part II
Journal of the Royal Society of Medicine
|July 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
Acta psychiatrica Scandinavica·2010
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?
Pharmacoepidemiology and drug safety·2004
The use of newly marketed drugs in children and adolescents prescribed in general practice.
Pharmacoepidemiology and drug safety·2004
Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies.
Pharmacoepidemiology and drug safety·2004
Safety profile of nicorandil--prescription-event monitoring (PEM) study.
Pharmacoepidemiology and drug safety·2004
Seven lessons for financial incentivisation schemes in healthcare: a qualitative study of NHS Resolution's Maternity Incentive Scheme.
Journal of the Royal Society of Medicine·2026
The historical development of sample size estimation: from Huygens and Bernoulli to the present.
Journal of the Royal Society of Medicine·2026
Alfred the Great: a diagnosis.
Journal of the Royal Society of Medicine·2026
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026